secretory use
secretory use, Total:19 items.
The international standard classification for "secretory use" includes: Radiographic equipment .
The Chinese standard classification for "secretory use" includes: Medical radiographic equipment .
Group Standards of the People's Republic of China
- T/SZJCH 0003-2022 General Technical Requirements for Cellular Exosomes
- T/QGCML 4542-2024 Exosome storage tank sealing tester
- T/LNSI 011-2024 Human amniotic epithelial stem cell derived exosomes
- T/LNSI 010-2024 Human amniotic mesenchymal stem cell derived exosomes
- T/FDSA 0049-2024 Specifications: Production and Testing of Exosomes Derived from Human Mesenchymal Stem Cells
- T/SHMHZQ 003-2022 General requirements for exosome extraction kits
Heilongjiang Provincial Standard of the People's Republic of China
- DB2306/T 155-2021 Technical regulations for body condition management of lactating dairy cows in large-scale pastures
Professional Standard - Agriculture
- 561药典 化学药和生物制品卷-2010 Chapter 7 Urinary System Drugs Section 3 Urinary System Special Drugs 3. Erectile Dysfunction Drugs Sildenafil Citrate
- 560药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications II. Drugs for the Treatment of Prostate Cancer (II) Luteinizing Hormone-releasing Hormone Analog Triptorelin Acetate
- 563药典 化学药和生物制品卷-2010 Chapter 7 Urinary System Drugs Section 3 Urinary System Special Drugs 3. Tadalafil Drugs for Erectile Dysfunction
- 550药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist terazosin hydrochloride
- 552药典 化学药和生物制品卷-2010 Chapter VII Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist tamsulosin hydrochloride
- 562药典 化学药和生物制品卷-2010 Chapter 7 Urinary System Medications Section 3 Urinary System Special Medications 3. Erectile Dysfunction Drugs Vardenafil Hydrochloride
- 551药典 化学药和生物制品卷-2010 Chapter VII Urinary System Drugs Section III Special Drugs for Urinary System 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist doxazosin mesylate
- NY/T 2873-2015 Evaluation method of pesticide endocrine disrupting effects
- 549药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist alfuzosin hydrochloride
Professional Standard - Medicine
- YY/T 0936-2014 Particular specifications for urology X-ray equipment
SCC
- AWWA WQTC59003 Endocrine Disruptor & Pharmaceutical Analysis Using Direct-Injection LC/MS/MS
- AWWA WQTC69484 Regenerating Spent Zeolites with UV and UV/H2O2 to Enhance Removal of Endocrine Disrupting Compounds
Secretion detection,secretory device,U.S.,Secretobacteria,Secretosome diameter,Secretosomes,Exosome Imaging,secretory components,secretory time,secretory instrument,Chromatographic secretion,Plant secretions,Granular secretion,fungal exudates,secretory hyperthermia,Secretosome research,Secretion spectrum,secretory artificial,secretory environment,secretory use